What You Should Know:
– Innovaccer Inc., a healthcare AI company, announced today a $275M Series F funding round.
– The latest investment, combined with primary and secondary funding, includes participation from prominent investors such as B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
Focus on AI-Powered Solutions
Innovaccer plans to introduce multiple AI copilots and agents to its comprehensive suite of offerings, including solutions for utilization management, prior authorization, clinical decision support, clinical documentation, care management, and contact centers. These AI-powered tools will further streamline healthcare operations, enhance efficiency, and improve patient outcomes.
Recent Traction/Milestones
Innovaccer’s commitment to excellence is reflected in its Best-in-KLAS recognition across multiple categories, including Data and Analytics, Population Health Management, and CRM. The company’s platform now supports over 130 leading healthcare organizations, including 6 of the top 10 health systems. Innovaccer has experienced remarkable growth, achieving a 50% year-over-year revenue increase for the past five years. The company has also expanded its public sector partnerships and recently acquired two companies, Cured and Pharmacy Quality Solutions, further strengthening its capabilities.
“Innovaccer is dedicated to transforming healthcare through data-driven insights and cutting-edge AI technology. We are grateful for the confidence our investors have in our vision and capabilities. This funding will enable us to push the boundaries of what’s possible in healthcare AI,” said Abhinav Shashank, Co-founder and CEO of Innovaccer. “Our goal is to make healthcare more proactive, predictive, and personalized.”
